Compounds > 1,3,4-oxadiazole
Page last updated: 2024-08-26

1,3,4-oxadiazole and Acute Confusional Senile Dementia

1,3,4-oxadiazole has been researched along with Acute Confusional Senile Dementia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Ashraf, M; Bao, X; Hussain, S; Khan, IU; Khan, MA; Mutahir, S; Mutahir, Z; Stark, CBW; Tariq, S; Zhou, B1
Almahmoud, SA; Chigurupati, S; Fatima, B; Felemban, SG; Khan, KM; Salar, U; Saleem, F; Shah, STA; Taha, M; Tariq, SS; Ul-Haq, Z1
Sharma, P; Shrivastava, SK; Singh, SP; Singh, SS; Tripathi, A; Tripathi, PN1
Choubey, PK; Saraf, P; Seth, A; Sharma, P; Shrivastava, SK; Tripathi, A1
Choubey, PK; Seth, A; Shrivastava, SK; Tripathi, A; Tripathi, MK1

Other Studies

5 other study(ies) available for 1,3,4-oxadiazole and Acute Confusional Senile Dementia

ArticleYear
Synthesis, in Vitro Cholinesterase Inhibition, Molecular Docking, DFT, and ADME Studies of Novel 1,3,4-Oxadiazole-2-Thiol Derivatives.
    Chemistry & biodiversity, 2022, Volume: 19, Issue:8

    Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds

2022
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies.
    Archiv der Pharmazie, 2023, Volume: 356, Issue:12

    Topics: Acarbose; Acetylcholinesterase; alpha-Amylases; alpha-Glucosidases; Alzheimer Disease; Butyrylcholinesterase; Diabetes Mellitus; Humans; Molecular Docking Simulation; Oxadiazoles; Structure-Activity Relationship

2023
Novel Molecular Hybrids of
    ACS chemical neuroscience, 2019, 10-16, Volume: 10, Issue:10

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Drug Design; Molecular Docking Simulation; Oxadiazoles; Piperidines; Rats; Structure-Activity Relationship

2019
Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
    Bioorganic chemistry, 2020, Volume: 95

    Topics: Acetylcholinesterase; Administration, Oral; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Coumaric Acids; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Male; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Oxadiazoles; Protein Aggregates; Rats; Rats, Wistar; Scopolamine; Structure-Activity Relationship

2020
Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease.
    Bioorganic chemistry, 2021, Volume: 111

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Male; Maze Learning; Molecular Structure; Neuroprotective Agents; Oxadiazoles; Peptide Fragments; Pyrrolidines; Rats; Rats, Wistar; Structure-Activity Relationship

2021